T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Groupon
GRPN
$885M
| $208K | ﹤0.01% |
18,389
+50
| +0.3% | +$821 |
|
|
KALV
2577
DELISTED
KalVista Pharmaceuticals
KALV
| $207K | ﹤0.01% |
20,999
+2,672
| +15% | +$29.5K |
|
|
SHCR
2578
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $207K | ﹤0.01% |
131,057
+30,057
| +30% | +$73.8K |
|
|
PSTL
2579
Postal Realty Trust
PSTL
$705M
| $206K | ﹤0.01% |
13,809
+204
| +1% | +$3.26K |
|
2580
Vuzix
VUZI
$219M
| $206K | ﹤0.01% |
29,048
-1,769
| -6% | -$10.4K |
|
2581
Westwood Holdings Group
WHG
$188M
| $206K | ﹤0.01% |
14,900
| – | – |
|
|
TCS
2582
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $206K | ﹤0.01% |
2,207
+546
| +33% | +$61.9K |
|
2583
Grid Dynamics Holdings
GDYN
$632M
| $205K | ﹤0.01% |
12,168
+454
| +4% | +$7.42K |
|
|
EXPR
2584
DELISTED
Express, Inc.
EXPR
| $205K | ﹤0.01% |
5,224
+1,987
| +61% | +$119K |
|
2585
Codexis
CDXS
$178M
| $203K | ﹤0.01% |
19,363
+419
| +2% | +$5.25K |
|
2586
Kinross Gold
KGC
$31.7B
| $203K | ﹤0.01% |
57,037
| – | – |
|
2587
Alphatec Holdings
ATEC
$1.5B
| $202K | ﹤0.01% |
+30,928
| New | +$285K |
|
2588
Flexsteel Industries
FLXS
$302M
| $202K | ﹤0.01% |
+11,200
| New | +$224K |
|
2589
Greenlight Captial
GLRE
$513M
| $202K | ﹤0.01% |
26,099
+122
| +0.5% | +$896 |
|
2590
Hawthorn Bancshares
HWBK
$277M
| $202K | ﹤0.01% |
+8,222
| New | +$200K |
|
|
PRMW
2591
DELISTED
Primo Water Corporation
PRMW
| $202K | ﹤0.01% |
15,068
+995
| +7% | +$14K |
|
|
AGTC
2592
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $202K | ﹤0.01% |
262,055
| – | – |
|
|
BNFT
2593
DELISTED
Benefitfocus, Inc.
BNFT
| $201K | ﹤0.01% |
25,778
-4,397
| -15% | -$43.4K |
|
2594
ADT
ADT
$5.4B
| $198K | ﹤0.01% |
32,135
-2,195
| -6% | -$15.3K |
|
|
GHL
2595
DELISTED
Greenhill & Co., Inc.
GHL
| $198K | ﹤0.01% |
21,528
-1,277
| -6% | -$15.7K |
|
2596
ACV Auctions
ACVA
$1.36B
| $197K | ﹤0.01% |
30,060
+17,166
| +133% | +$177K |
|
2597
Goldgroup Mining Inc.
GORO
$210M
| $197K | ﹤0.01% |
120,708
+5,048
| +4% | +$9.92K |
|
2598
PureCycle Technologies
PCT
$1.44B
| $197K | ﹤0.01% |
26,538
-18,393
| -41% | -$154K |
|
|
KLRS
2599
Kalaris Therapeutics
KLRS
$94.3M
| $197K | ﹤0.01% |
2,200
+1,005
| +84% | +$105K |
|
2600
Vera Bradley
VRA
$94.7M
| $196K | ﹤0.01% |
45,200
+7,859
| +21% | +$48K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.